| General Information of This Metabolic Reaction (MR) (ID:
MR001861) |
| Formula |
|
| Reactant |
Oxaliplatin |
Product |
Pt(DACH) Cl2 |
|
Reactant Info
|
Product Info
|
|
|
|
|
|
|
|
| Other MR(s) Related to The Reactant of This MR |
|
Other MR(s) That Metabolize The Reactant of This MR
|
|
|
| References |
| 1 |
Roles of Transient Receptor Potential Ankyrin 1 in Oxaliplatin-Induced Peripheral Neuropathy Biol Pharm Bull. 2017;40(7):947-953. doi: 10.1248/bpb.b17-00243.
|
| 2 |
Analytical Methods for Oxalate Quantification: The Ubiquitous Organic Anion. Molecules. 2023 Apr 4;28(7):3206. doi: 10.3390/molecules28073206.
|
| 3 |
Protein-Based Delivery Systems for Anticancer Metallodrugs: Structure and Biological Activity of the Oxaliplatin/-Lactoglobulin Adduct. Pharmaceuticals (Basel). 2022 Mar 30;15(4):425. doi: 10.3390/ph15040425.
|
| 4 |
Nano-scale imaging of dual stable isotope labeled oxaliplatin in human colon cancer cells reveals the nucleolus as a putative node for therapeutic effect. Nanoscale Adv. 2020 Nov 26;3(1):249-262. doi: 10.1039/d0na00685h.
|
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.
